Sign in

    Michael Pollock

    Director and Senior Analyst at Wolfe Research, LLC

    Michael Pollock is a Director and Senior Analyst at Wolfe Research, LLC, specializing in the coverage of utilities and power sector equities. He covers major publicly traded companies such as Exelon, NextEra Energy, Dominion Energy, and Duke Energy, and is known by institutional clients for in-depth relative value analysis and sector outlook. Joining Wolfe Research in 2021 after serving in senior analyst roles at Evercore ISI, Pollock brings over two decades of professional experience on both the buy-side and sell-side, with previous tenures at Barclays, Evercore, and other leading firms. He holds FINRA Series 7, 63, 86, and 87 licenses, and is recognized for his sharp industry insights and high client engagement, although publicly disclosed performance metrics and tip rankings are not available.

    Michael Pollock's questions to Nyxoah (NYXH) leadership

    Michael Pollock's questions to Nyxoah (NYXH) leadership • Q2 2025

    Question

    Michael Pollock from Wolfe Research asked for confirmation of Nexeo's U.S. pricing strategy relative to its competitor and inquired about what level of commitment, such as a share of patient wallet, the company asks from surgeons it trains on the GENEO system.

    Answer

    CEO Olivier Talman confirmed that the company will use the same CPT code and follow the associated pricing strategy, implying price parity with its competitor. Regarding surgeon commitment, he explained that instead of asking for a market share percentage, Nexeo requires physicians to identify five qualified patient cases before they are trained, ensuring they are prepared to begin implanting immediately and move through the learning curve.

    Ask Fintool Equity Research AI